(Q46666583)

24 December 2017

editorial

0 references

title

Early prediction of response to therapy: the clinical implications in Hodgkin's and non-Hodgkin's lymphoma (English)

1 reference

24 December 2017

author name string

Lale Kostakoglu

series ordinal

1

1 reference

24 December 2017

publication date

1 August 2008

1 reference

24 December 2017

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

24 December 2017

volume

35

1 reference

24 December 2017

issue

8

1 reference

24 December 2017

page(s)

1413-1420

1 reference

24 December 2017

[(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-008-0787-0

Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

12 December 2020

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

12 December 2020

Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study

1 reference

12 December 2020

MACOP-B treatment for advanced stage diffuse large cell lymphoma: a multicenter Italian Study

1 reference

12 December 2020

Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography

1 reference

12 December 2020

COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma

1 reference

12 December 2020

Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results

1 reference

12 December 2020

Revised response criteria for malignant lymphoma

1 reference

12 December 2020

Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma.

1 reference

12 December 2020

A Gompertzian model of human breast cancer growth.

1 reference

12 December 2020

The Norton-Simon hypothesis revisited

1 reference

12 December 2020

The management of patients with limited-stage classical Hodgkin lymphoma

1 reference

12 December 2020

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study

1 reference

12 December 2020

Advances in biology, diagnostics, and treatment of Hodgkin's disease

1 reference

12 December 2020

1 reference

12 December 2020

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

1 reference

12 December 2020

Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease.

1 reference

12 December 2020

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

12 December 2020

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.

1 reference

12 December 2020

Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.

1 reference

12 December 2020

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease

1 reference

12 December 2020

High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multice

1 reference

12 December 2020

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

12 December 2020

Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group

1 reference

12 December 2020

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

1 reference

12 December 2020

Hodgkin disease/lymphoma. Clinical practice guidelines in oncology

1 reference

12 December 2020

18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT

1 reference

12 December 2020

The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.

1 reference

12 December 2020

Routine use of PET scans after completion of therapy in pediatric Hodgkin disease results in a high false positive rate

1 reference

12 December 2020

High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis.

1 reference

12 December 2020

Overview of non-Hodgkin[apos ]s lymphoma: Biology, staging, and treatment

1 reference

12 December 2020

Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.

1 reference

12 December 2020

VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group

1 reference

12 December 2020

The role of serial pre-transplantation positron emission tomography in predicting progressive disease in relapsed lymphoma.

1 reference

12 December 2020

Combination chemotherapy for the treatment of diffuse aggressive lymphomas: F-MACHOP update

1 reference

12 December 2020

Current treatment strategies in early stage Hodgkin's disease

1 reference

12 December 2020

Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80)

1 reference

12 December 2020

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

1 reference

12 December 2020

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

1 reference

12 December 2020

Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma

1 reference

12 December 2020

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.

1 reference

12 December 2020

Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin's lymphoma in three randomised EORTC trials.

1 reference

12 December 2020

Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria.

1 reference

12 December 2020

Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions

1 reference

12 December 2020

The significance of the residual mediastinal mass in treated Hodgkin's disease

1 reference

12 December 2020

Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.

1 reference

12 December 2020

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

12 December 2020

High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study

1 reference

12 December 2020

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

1 reference

12 December 2020

FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.

1 reference

12 December 2020

Hodgkin lymphoma: Response assessment by revised International Workshop Criteria.

1 reference

12 December 2020

A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary rep

1 reference

12 December 2020

10.1007/S00259-008-0787-0

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017